OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,644 JPY | +0.97% |
|
+6.87% | +29.55% |
| Jun. 05 | Olympus Skips Buyback in May | MT |
| May. 27 | Olympus Enters into Put Option Agreement for Orthopedic Business Transfer | MT |
| Sales 2024 | 936B 5.97B | Sales 2025 * | 1,001B 6.38B | Capitalization | 3,081B 19.64B |
|---|---|---|---|---|---|
| Net income 2024 | 243B 1.55B | Net income 2025 * | 118B 749M | EV / Sales 2024 | 2.75 x |
| Net cash position 2024 * | 78.83B 503M | Net Debt 2025 * | 1.92B 12.25M | EV / Sales 2025 * | 3.08 x |
| P/E ratio 2024 |
11.1
x | P/E ratio 2025 * |
26.2
x | Employees | 32,844 |
| Yield 2024 |
0.81% | Yield 2025 * |
0.75% | Free-Float | 94.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | +0.97% | ||
| 1 week | +6.87% | ||
| Current month | +6.87% | ||
| 1 month | +15.74% | ||
| 3 months | +23.56% | ||
| 6 months | +25.02% | ||
| Current year | +29.55% |
1 week
2 451.50
2 654.50
1 month
2 219.002 654.50
Current year
1 935.502 654.50
1 year
1 782.002 654.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
758.753 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 61 | 19-05-31 |
Gary Pruden
BRD | Director/Board Member | 62 | 22-05-31 |
Yasushi Shingai
BRD | Director/Board Member | 68 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 29 M€ | +16.11% | ||
| 2.11% | 10 M€ | +15.70% | - | |
| 1.55% | 240 M€ | +18.59% | ||
| 1.23% | 28,050 M€ | +16.51% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 2,644 | +0.97% | 3,910,700 |
| 24-06-06 | 2,618 | +1.67% | 5,295,200 |
| 24-06-05 | 2,575 | +2.51% | 6,072,000 |
| 24-06-04 | 2,512 | +0.62% | 3,697,900 |
| 24-06-03 | 2,496 | +0.93% | 3,858,800 |
Delayed Quote Japan Exchange, June 07, 2024 at 02:00 am EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-08-06
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
2,644
JPY
Average target price
2,684
JPY
Spread / Average Target
+1.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.55% | 19.56B | |
| +9.48% | 221B | |
| +13.72% | 198B | |
| +23.79% | 148B | |
| +33.39% | 112B | |
| +4.75% | 66.85B | |
| +15.59% | 52.84B | |
| +3.16% | 50.86B | |
| -4.35% | 38.75B | |
| -1.27% | 35.15B |
- Stock Market
- Equities
- 7733 Stock
